MuredachPReillyMD
Cardiology • New York, NYAdult Congenital Heart Disease
Associate Dean for Clinical and Translational Research, Director, Cardiometabolic Precision Medicine Program, Director, Irving Institute for Clinical and Translational Research, Florence and Herbert Irving Endowed Professor of Medicine at NewYork-Presbyterian and Columbia
Overview of Dr. Reilly
Dr. Muredach Reilly is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University College of Dublin National Univ SOM and has been in practice 29 years. Dr. Reilly accepts several types of health insurance, listed below. He is one of 686 doctors at New York-Presbyterian Hospital and one of 326 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Office
622 West 168th Street
New York, NY 10032
Education & Training
University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 1995 - 2000- University of Pennsylvania Health SystemResidency, Internal Medicine, 1994 - 1995
University College of Dublin National Univ SOMClass of 1988
Certifications & Licensure
NY State Medical License 2016 - 2026
PA State Medical License 1995 - 2016
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2010
- Join now to see all
Clinical Trials
- Carotid Atherosclerosis Regression at Magnetic Resonance Assessment. Start of enrollment: 2000 Jan 01
- Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus Start of enrollment: 2002 Sep 01
- The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- PRDM16 controls smooth muscle cell fate in atherosclerosis.Josephine M E Tan, Lan Cheng, Ryan P Calhoun, Angela H Weller, Karima Drareni
Biorxiv. 2025-02-23 - 1 citationsPrediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using machine learning.Ree Lu, Heidi S Lumish, Kohei Hasegawa, Mathew S Maurer, Muredach P Reilly
European Journal of Heart Failure. 2025-02-01 - Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP.Itsuki Osawa, Keitaro Akita, Kohei Hasegawa, Michael A Fifer, Albree Tower-Rader
Circulation. Heart Failure. 2025-02-01
Press Mentions
Columbia Awarded $61.7 Million to Accelerate Development of New Medical TreatmentsSeptember 13th, 2021- Three VP&S Scientists Selected as Paul A. Marks ScholarsJune 21st, 2021
- VP&S Names 2021 Gerstner ScholarsApril 5th, 2021
- Join now to see all
Grant Support
- Integration of spatial transcriptomics, genetics, and histomorphology for causal inference in atherosclerotic cardiovascular diseaseCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
- Integration of spatial transcriptomics, genetics, and histomorphology for causal inference in atherosclerotic cardiovascular diseaseCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
- Integration of spatial transcriptomics, genetics, and histomorphology for causal inference in atherosclerotic cardiovascular diseaseCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
- Integration of spatial transcriptomics, genetics, and histomorphology for causal inference in atherosclerotic cardiovascular diseaseCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
- Integration of spatial transcriptomics, genetics, and histomorphology for causal inference in atherosclerotic cardiovascular diseaseCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2028
- Postdoctoral Training in Arteriosclerosis ResearchCOLUMBIA UNIVERSITY HEALTH SCIENCES1978–2028
- Postdoctoral Training in Arteriosclerosis ResearchCOLUMBIA UNIVERSITY HEALTH SCIENCES1978–2028
- Postdoctoral Training in Arteriosclerosis ResearchCOLUMBIA UNIVERSITY HEALTH SCIENCES1978–2028
- Postdoctoral Training in Arteriosclerosis ResearchCOLUMBIA UNIVERSITY HEALTH SCIENCES1978–2028
- Postdoctoral Training in Arteriosclerosis ResearchCOLUMBIA UNIVERSITY HEALTH SCIENCES1978–2028
- Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease riskCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease riskCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease riskCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease riskCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease riskCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease riskCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2026
- Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Clinical and Translational Science AwardCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Computational and functional strategies to decipher lncRNAs in human atherosclerosisCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Creation of an Institutional Biobanking FacilityCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Creation of an Institutional Biobanking FacilityCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Elucidation Of Tissue-Specific Transcriptomic Profiles In Cardiometabolic DiseaseNational Heart, Lung, And Blood Institute2012
- Mentored Patient Oriented Research In Cardiometabolic DiseaseNational Heart, Lung, And Blood Institute2011–2012
- Fractalkine In Adipose Inflammation And Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Glycomics Of Heart And Lung Disease In The Genomic ERANational Heart, Lung, And Blood Institute2011
- Roche C501/E411 Autoanalyzer For CTSA Core Resources At PENN And CHOPNational Center For Research Resources2010
- Genetics Of Atherosclerosis In Renal DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Inflammatory And Metabolic Insults To The VasculatureNational Heart, Lung, And Blood Institute2006
- Inflammation, The Metabolic Syndrome And AtherosclerosisNational Heart, Lung, And Blood Institute2003–2006
- PENN Diabetes Heartheart StudyNational Center For Research Resources2005
- ACTG - A5078: Carotid Artry Intima-Media Thickness In Hiv-Infected AdultsNational Center For Research Resources2005
- The Effect Of Protein Kinase C (PKC) B Specific InhibitorNational Center For Research Resources2004–2005
- Magnetic Resonance Characterization Of Carotid Atherosclerotic Plaque In VivoNational Center For Research Resources2004–2005
- Inflammation And The Metabolic Syndrome In HumansNational Center For Research Resources2004–2005
- PENN Diabetes Heart StudyNational Center For Research Resources2004
- Carotid Artery Intima-Media Thickness In Hiv-Infected ADNational Center For Research Resources2004
- Mentored Patient-Oriented Research Career Development AwNational Center For Research Resources2001–2004
- Mentored Patient-Oriented Research Career Development AwNational Center For Research Resources2000
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Horizon BCBS Direct AccessHorizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
